According to guideline of USFDA an antacid must have a Acid Neutralizing capacity > 5 mEq (milliequivalent) and an effective antacid must have higher and prolonged acid neutralization capacity. Orion Pharma Ltd. Introduces 1st time in Bangladesh- Novelta, A novel antacid. A comparative study was performed to compare the acid neutralizing capacity of all the available antacids. Among them, Magaldrate and Simethicone combination (Novelta) has the higher acid neutralizing capacity.
A novel antacid to treat Hyperacidity, Heartburn, Gastric & Duodenal Ulcer, Dyspepsia, GERD & Flatulence
Indications Hyperacidity, Gastric & Duodenal ulcer, Gastritis, Heartburn, Dyspepsia, Gastroesophageal reflux. Also indicated for the relief of Flatulence, Abdominal distention and Windy colic.
Dosage and Administration 2-4 teaspoonful (10-20 ml) or1-4 tablets of Novelta chewable tablet, 20 minutes to 1 hour after meals and at bedtime, or as directed by physician.
Available as: Novelta Suspension 100 ml Novelta Suspension 200 ml Novelta Chewable Tablet."
